By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK translational genomics firm Horizon Discovery said that it has joined a personalized medicine consortium created last year to apply functional genomics to develop drugs and identify biomarkers that may be predictive of drug responses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.